FDA Inspection 1110333 — General Hospital Corporation (The)

General Hospital Corporation (The) — FEI 1270485

The FDA completed an inspection of General Hospital Corporation (The) on October 23, 2019 in Boston, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
October 23, 2019
Fiscal Year
2020
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Boston, MA (United States)